FindTrial
Sign In

ROLE OF HOMOEOPATHIC MEDICINES IN BRONCHIAL ASTHMA

A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN BRONCHIAL ASTHMA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039456
Enrollment
38
Registered
2022-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma Health Condition 2: J459- Other and unspecified asthma

Interventions

Control Intervention1: not applicable: not applicable

Sponsors

Dr Shweta sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All Pre-diagnosed and New cases based on symptomatology of bronchial asthma. 2.Patient within the age group of 5-40 years. 3.Both sexes..

Exclusion criteria

Exclusion criteria: 1.Cases required surgical intervention. 2.Cases with other respiratory disorder like bronchitis, emphysema, tuberculosis, silicosis etc. will be excluded from the study. 3.Cases with other systemic disorders like HIV, Hepatitis, malignancies etc.

Design outcomes

Primary

MeasureTime frame
Effectivenss would be assessed using mini asthma quality of life questionaaireTimepoint: it will be applied at the baseline and at the end of three months—

Secondary

MeasureTime frame
any effect on quality of lifeTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Shweta Sharma

Dr. S. R Rajasthan ayurved university jodhpur

principalskhmc@gmail.com9414229555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026